Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Noladin ether

Cannabinoid receptor ligand
BML-FA033-0005 5 mg 204.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-340-052

Endogenous cannabinoid agonist isolated from porcine brain. Binds specifically to CB1 (Ki=21.2nM) and CB2 (Ki=>3µM) receptors. Causes sedation hypothermia, intestinal immobility and mild antinociception in mice. Chemically stable, but less potent than 2-arachidonoylglycerol (Prod. No. BML-FA028) with an endogenous half-life time of hours rather than minutes.

Product Details

Alternative Name:2-Arachidonyl glyceryl ether, 2-AG ether, 5Z,8Z,11Z,14Z-Eicosatetraen-2-glyceryl ether
Purity:≥98% (TLC)
Appearance:Yellow oil.
Solubility:Soluble in DMSO (40mg/ml) or ethanol (25mg/ml).
Shipping:Ambient Temperature
Long Term Storage:-20°C
Use/Stability:Stable for at least 1 year after receipt when stored, as supplied, at -20°C. Stock solutions are stable for up to 3 months at -20°C when stored under an atmosphere of argon or nitrogen.
Handling:Protect from oxygen. Keep under inert gas.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors: J.L. Shoemaker, et al.; J. Pharmacol. Exp. Ther. 315, 828 (2005), Abstract;
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice: Y. Avraham, et al.; Brain Res. Bull. 65, 117 (2005), Abstract;
Further advances in the synthesis of endocannabinoid-related ligands: A. Mahadevan and R.K. Razdan; AAPS J. 7, E496 (2005), Abstract; Full Text
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors: J.L. Shoemaker, et al.; J. Pharmacol. Exp. Ther. 314, 868 (2005), Abstract;
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion: K. Nithipatikom, et al.; Cancer Res. 64, 8826 (2004), Abstract; Full Text
Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor: M. Duncan, et al.; Br. J. Pharmacol. 142, 509 (2004), Abstract; Full Text
Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors: G. Appendino, et al.; Bioorg. Med. Chem. Lett. 13, 43 (2003), Abstract;
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid: K. Laine, et al.; Invest. Ophthalmol. Vis. Sci. 43, 3216 (2002), Abstract;
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues: F. Fezza, et al.; FEBS Lett. 513, 294 (2002), Abstract;
2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor: L. Hanus, et al.; PNAS 98, 3662 (2001), Abstract;

Product Toolbox


Certificate of Analysis


By target:
Cannabinoid receptor
By biological activity:
Cannabinoid receptor Ligand
By catalog section:


Technical Service
Customer Service

Related Literature

Download as PDF

All new literature pieces